“We’re proposing that the government use its authorization for government patent use to allow generic manufacturers…to bring [remdesivir] into the United States so that when we have more and more cases that we don’t have to sit at the bedside and worry about whether we’re going to run out of drug tomorrow.” Dr. Rochelle Walensky, Chief of Infectious Diseases, Massachusetts General Hospital